Memorial Sloan-Kettering
FDA Recognizes Portion of MSK Oncology Knowledge Base in Public Human Genetic Variant Database
MSK's OncoKB is the first collection of somatic variants that the FDA has accepted for test developers to use in premarket validation studies.
New York City Opening Dedicated COVID-19 Testing Laboratory
The Manhattan-based lab will scale its capacity to process 20,000 tests per day by November and provide results dedicated to the city.
Paige Receives FDA Clearance for Digital Pathology Viewer With Philips Scanner
Paige said that the regulatory clearance paves the way for the in vitro diagnostic use of FullFocus with additional IVD whole slide imaging scanners.
Guardant360 Results in Alpelisib Trial Suggest Liquid Biopsy May Help Better Capture Non-Responders
A study of both tissue and blood samples from patients in a small trial found that liquid biopsy may detect putative resistance mutations missed in tissue.
The company said it has seen progress in efforts to get FDA approval for its tissue and liquid biopsy tests as data continues to accumulate for pan-cancer utility.
Apr 24, 2019
Feb 28, 2018